Bio-Rad Laboratories Class A
456 hedge funds and large institutions have $6.17B invested in Bio-Rad Laboratories Class A in 2024 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 148 increasing their positions, 147 reducing their positions, and 56 closing their positions.
45% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 56
32% more call options, than puts
Call options by funds: $5.22M | Put options by funds: $3.94M
4% more funds holding
Funds holding: 437 → 456 (+19)
1% more repeat investments, than reductions
Existing positions increased: 148 | Existing positions reduced: 147
3.24% less ownership
Funds ownership: 85.21% → 81.97% (-3.2%)
5% less capital invested
Capital invested by funds: $6.5B → $6.17B (-$329M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$61.7M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$31.1M |
| 3 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$29.7M |
| 4 |
BlackRock
New York
|
+$27.7M |
| 5 |
Morgan Stanley
New York
|
+$20.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VanEck Associates
New York
|
-$197M |
| 2 |
Select Equity Group
New York
|
-$84.1M |
| 3 |
Millennium Management
New York
|
-$69.5M |
| 4 |
VAM
Veritas Asset Management
London,
United Kingdom
|
-$37.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$23M |
BIO Hedge Fund Activity: Q4 2024 in Review
456 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2024, worth a combined $6.17B — down 5.1% from $6.5B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new BIO positions and 56 closed out — a net gain of 25 holders — while 148 added to existing stakes and 147 trimmed.
The largest buyer was Ariel Investments, adding an estimated $61.7M. The largest seller was VanEck Associates, cutting an estimated $197M.
- 456 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2024, up from 437 in Q3 2024.
- Funds reported $6.17B of Bio-Rad Laboratories Class A stock for Q4 2024, down 5.1% quarter-over-quarter.
- 81 funds opened new Bio-Rad Laboratories Class A positions in Q4 2024 and 56 closed out, a net change of +25 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q4 2024 was Ariel Investments, an estimated $61.7M added.
- The largest Bio-Rad Laboratories Class A seller in Q4 2024 was VanEck Associates, an estimated $197M sold.
Based on aggregated 13F filings for Q4 2024.